Remarkably, increasing evidence also points toward GPX4 protein degradation as a means to incite cancer cell ferroptosis and apoptosis in hepatocellular carcinoma and breast cancer cells [221–223]. This evidence concerns the gene GPX4 and hepatocellular carcinoma.